WebJul 1, 2015 · JUPITER was largely responsible for changing the guidelines for cholesterol lowering drugs, as in addition to adult diabetics, most healthy people over the age of 50 … Weblowering drug trials, the JUPITER (Justification for the Use of Statins in Primary Prevention) trial is unique: it reports a substantial decrease in the risk of cardiovascu-lar diseases …
Statins
WebAug 11, 2012 · In an analysis limited to participants who developed diabetes during the JUPITER trial (n=270 on rosuvastatin, 216 on placebo), 18 primary cardiovascular endpoints occurred. Of these, eight were on rosuvastatin (incidence rate 1·10 per 100 person-years) and ten were on placebo (1·73 per 100 person-years). WebJUPITER is an acronym for Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin. It was an AstraZeneca sponsored randomized double-blind … ping rewards
Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless ...
WebNov 12, 2013 · In November 2008, the JUPITER trial was published in the New England Journal of Medicine. JUPITER is an acronym for Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin.It was an AstraZeneca sponsored randomized double-blind trial comparing rosuvastatin 20 mg with placebo in 17,802 … WebIn 2008, the JUPITER trial showed statins provided benefit in those who had no history of high cholesterol or heart disease, but only in those with elevated high-sensitivity C-reactive protein (hsCRP) levels, an indicator for inflammation. WebMar 2, 2015 · Statins are currently recommended for primary prevention of cardiovascular disease in high-risk patients. The JUPITER trial was designed to assess whether … ping result destination host unreachable